Nanox to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025

Rhea-AI Summary

Nanox (NASDAQ: NNOX), a medical imaging technology company, has scheduled its fourth quarter and fiscal year 2024 financial results announcement for March 31, 2025, before market open. The company will host a conference call at 8:30 a.m. ET featuring CEO and Acting Chairman Erez Meltzer and CFO Ran Daniel to discuss the results and provide a business update.

News Market Reaction – NNOX

-1.54%

-1.54% Session move

In the trading session that priced this news, NNOX declined 1.54%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PETACH TIKVA, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2024, before market open on Monday, March 31, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.

Interested parties may register for the conference call using the following link: Nanox Q4 Earnings Call Registration. The live webcast of the conference call may be accessed by using the following link: Nanox Q4 Earnings Webcast. The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations. 

About Nanox

Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by bringing a full solution of affordable medical imaging technologies based on advanced AI and proprietary digital X-ray source.

Nanox's vision encompasses expanding the reach of Nanox technology both within and beyond hospital settings, providing a seamless end-to-end solution from scan to diagnosis, leveraging AI for more accurate diagnostics and maintaining a clinically driven approach. The Nanox ecosystem includes Nanox.ARC – a multi-source digital tomosynthesis system that is cost-effective and user-friendly; Nanox.AI LTD, a subsidiary of Nanox Imaging, is an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic diseases; Nanox.CLOUD – a cloud-based software platform that manages data collected by Nanox devices, and provides users with tools for in-depth imaging analysis; Nanox.MARKETPLACE – a proprietary decentralized marketplace through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts, and a comprehensive teleradiology services platform. By improving early detection and treatment, Nanox aims to enhance better health outcomes worldwide. For more information, please visit www.nanox.vision.

Contacts

Media Contact
ICR Healthcare
NanoxPR@icrinc.com

Investor Contact
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com

FAQ

When will Nanox (NNOX) release its Q4 2024 earnings report?

Nanox will release its Q4 and fiscal year 2024 earnings report on March 31, 2025, before market open.

What time is the Nanox (NNOX) Q4 2024 earnings conference call?

The earnings conference call is scheduled for 8:30 a.m. ET on March 31, 2025.

Who will be presenting at the Nanox (NNOX) Q4 2024 earnings call?

CEO and Acting Chairman Erez Meltzer and CFO Ran Daniel will host the conference call.

How can investors access the Nanox (NNOX) Q4 2024 earnings call?

Investors can register for the conference call through a registration link or access the live webcast through the Investor Relations section of the Nanox website.